Home
Synerlab

Synerlab Market Share Analysis for February 2026

Spécialisés dans le développement et la production de petites et moyennes séries pour l’industrie pharmaceutique, nous soutenons la croissance de nos clients grâce à une offre agile de services et de produits adaptés aux besoins des patients.

Health > Biotechnology and Pharmaceuticals

Domainsynerlab.com

Year Founded2001

Employees1001 - 5000

Annual Revenue$200M - $500M

Synerlab

Synerlab (including company regionals)

synerlab.com

See more website traffic and engagement information

Synerlab Revenue up to February 2026 is 200M - 500M

revenue generated by Synerlab top domains

Synerlab top domains revenue over 3 years

Revenue for Synerlab top domains

synerlab.com200M - 500M

See more with Sales Intelligence

Total visits to Synerlab's top domains

Understand Synerlab market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

synerlab.com588

See more with Sales Intelligence

Avg. visit duration in Synerlab's top domains

Analyze Synerlab engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

synerlab.com00:00:21

See more with Sales Intelligence

Avg. pageviews on Synerlab's top domains

See how Synerlab keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

synerlab.com2.14

See more with Sales Intelligence

Synerlab top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Synerlab

These are the website technologies, by industry, used by Synerlab top domains

Widget (6)

Twemoji

Conversion & Analytics (3)

Google Analytics

Social (3)

Instagram

Advertising (2)

DoubleClick

More Technologies

9

See all

News & Signals from Synerlab

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsBlue Wolf Capital Partners LLC acquires Synerlab Group.Blue Wolf Capital Partners finalizes the acquisition of seven European pharmaceutical manufacturing facilities from Recipharm and plans to acquire Synerlab, aiming to establish a leading CDMO.

NewsSynerlab Group acquires Alcala Farma.Private-equity backed contractor Synerlab has bought Spain’s Alcala Farma in a bid to expand its European reach and revenue base.